Bpifrance

Activity from announced rounds

All recorded activity

Bpifrance is France’s public investment bank, financing businesses through equity, loans and guarantees and supporting innovation and international expansion.

Its equity activity includes venture capital, growth investment and investments in other funds. Innovation financing can also support research, development and bringing a product to market, so founders may have financing options beyond a conventional equity round.

The appropriate route depends on the project and stage: research funding, a guarantee for borrowing, direct investment and export support serve different needs. Its bank-for-entrepreneurs model connects those instruments with programmes for developing a French business.

Sources
Rounds participated in
28
Confirmed lead rounds
1
10 roles undisclosed
New companies
26
First participation on record · 2 follow-on
Funding in participating rounds
$5.2B
23 disclosed · full round size, not this investor’s share

By stage

Seed6
Series A6
Undisclosed6
Series C+5
Series B4
1 more
Pre-seed1

By primary sector

Biotech7
AI5
Fintech3
Foodtech3
Cybersecurity2
7 more
Healthtech2
Climate tech1
Edtech1
Enterprise software1
Hardware1
Robotics1
Space tech1

By country

France21
Belgium1
Denmark1
Finland1
Spain1
3 more
Switzerland1
United Kingdom1
United States1

Rounds

28 in all activity
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant
CarbonFarm

CarbonFarm helps rice producers and project developers measure emissions reductions and finance changes in farming practices.

€7MSeries A
Participant
Edonia

French foodtech company making protein-rich ingredients from spirulina.

€15MSeries A financing package including non-dilutive and bank funding
Participant
Spiko

Tokenized money-market infrastructure that gives businesses and investors access to cash yield.

$90MSeries B
Participant
Edison IA

Edison IA helps small and mid-sized businesses put AI to work through executive training, process diagnosis and deployed business agents.

€1MSeed
Participant
Hackuity

Hackuity consolidates vulnerability findings from security tools and helps organisations prioritise remediation against their actual exposure.

$19MSeries B
Participant
Delos

Delos sells autonomous AI workers that take on defined business tasks through a company’s messaging and software tools.

€10MSeries A
Participant
Kaiko

Market data, analytics and infrastructure that help financial institutions price, trade and manage risk in digital assets.

$57MSeries B-2 extension
Participant
Ed.ai

AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.

€5MSeed
Participant
One Biosciences

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

€3.3Mi-Démo 5 grant (France 2030)
Participant
MAASH

MAASH makes fermentation-derived mycoprotein ingredients for food manufacturers developing meat blends and alternative-protein products.

€12.2MEquity and public financing package
Participant
Brenus Pharma

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

€11MSeries A
Role not disclosed
Lys Therapeutics

Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke

Role not disclosed
Morpho Association

Morpho Association supports Morpho, an open blockchain credit network for lending, borrowing and embedded financial products.

$175MFunding round
Participant
Ona Therapeutics

Antibody-drug conjugates and antibody therapies for treatment-resistant cancers.

$86.6MSeries B
Participant
Quobly

Develops silicon qubits for dense integration and compatibility with industrial fabrication standards

€115MSeries A
Role not disclosed
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed
Omniscient

Provides AI-driven decision intelligence platform for boards and senior executives

$4.1MPre-Seed
Role not disclosed
Mistral AI

Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.

$830MGPU infrastructure financing
Participant
May Health

Provides medical device solutions for women living with polycystic ovary syndrome (PCOS)

$11.7MSeed
Role not disclosed
Verley

Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers

€32MSeries A
Role not disclosed
GitGuardian

Provides a non-human identity security platform to detect and remediate leaked secrets in code

$50MSeries C
Role not disclosed
Mistral AI

Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.

€1.2BStrategic
Role not disclosed
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed
Iceye

ICEYE builds and operates radar-imaging satellites and delivers Earth-observation data and intelligence to governments and businesses.

€150MSeries E
Participant
Mistral AI

Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.

€1.7BSeries C
Participant
Genesis AI

Genesis AI develops general-purpose robotics systems.

$105MSeed
Participant
Archeon Medical

Archeon Medical develops ventilation feedback devices that help emergency responders measure and adjust manual ventilation during resuscitation.

UndisclosedUndisclosed
Lead